Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;46(4):306-10.
doi: 10.1097/PAT.0000000000000097.

Nationwide prevalence of lymph node metastases in Gleason score 3 + 3 = 6 prostate cancer

Affiliations

Nationwide prevalence of lymph node metastases in Gleason score 3 + 3 = 6 prostate cancer

Jen-Jane Liu et al. Pathology. 2014 Jun.

Abstract

Based on revisions of Gleason scoring in 2005, it has been reported that nodal metastases at radical prostatectomy in Gleason 3 + 3 = 6 (GS6) prostate cancer are extremely rare, and that GS6 cancers with nodal metastases are invariably upgraded upon review by academic urological pathologists. We analysed the prevalence and determinants of nodal metastases in a national sample of patients with GS6 cancer.We utilised the SEER database to identify patients diagnosed with GS6 prostate cancer during 2004-2010 who had radical prostatectomy and ≥1 lymph node(s) examined. We calculated the prevalence of nodal metastases and constructed a multivariable logistic regression model to identify factors associated with nodal metastases. Among 21,960 patients, the prevalence of nodal metastases was 0.48%. Older age, preoperative PSA >10 ng/mL, and advanced stage were positively associated with nodal metastases. Lymph node metastases in GS6 cancer are more prevalent in a nationwide population compared to academic centres. Revised guidelines for Gleason scoring have made GS6 cancer a more homogeneously indolent disease, which may be relevant in the era of active surveillance. We submit that lymph node metastases in GS6 cancer be used as a proxy for adherence to the 2005 ISUP consensus on Gleason grading.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest and sources of funding: The authors state that there are no conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1
Percentage of GS6 patients with positive LN, 2004–2010.

Comment in

References

    1. Bailar JC, Mellinger GT, Gleason DF. Survival rates of patients with prostatic cancer, tumor stage, and differentiation—preliminary report. Cancer Chemother Rep. 1966;50:129–36. - PubMed
    1. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep. 1966;50:125–8. - PubMed
    1. Epstein JI, Allsbrook WC, Amin MB, et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29:1228–42. - PubMed
    1. Ross HM, Kryvenko ON, Cowan JE, et al. Do adenocarcinomas of the prostate with Gleason score (GS) 6 have the potential to metastasize to lymph nodes? Am J Surg Pathol. 2012;36:1346–52. - PMC - PubMed
    1. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2012 Sub (1973–2010 varying) Linked To County Attributes – Total US, 1969–2011 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch. released April 2013, based on the November 2012 submission. www.seer.cancer.gov.